Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious Disease

PUBLISHER: Grand View Research | PRODUCT CODE: 1813982

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1813982

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report By Disease (Dengue, Rabies, Trachoma, Chagas Disease), By Product (Drugs, Vaccines), By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Neglected Tropical Disease Treatment Market Summary

The global neglected tropical disease treatment market size was estimated at USD 3.96 billion in 2024 and is projected to reach USD 6.04 billion by 2033, growing at a CAGR of 4.78% from 2025 to 2033. The demand for these treatments is driven by the increasing prevalence of neglected tropical diseases in low-income regions, as well as advancements in drug development and global health initiatives aimed at eradicating these diseases.

Various global health initiatives, advancements in drug development, and innovative delivery methods greatly influence the neglected tropical disease treatment market. A major factor driving growth in this market is increasing attention from governments and international health organizations. The World Health Organization (WHO) has effectively coordinated mass drug administration (MDA) programs for diseases like lymphatic filariasis, trachoma, and soil-transmitted helminths. According to the World Health Organization (WHO), in April 2025, the United States withdrew funding from NTD programs, impacting 47 campaigns over 19 years. This withdrawal affected 143 million people and disrupted mass treatment efforts. The funding reductions also impeded research, threatening progress toward eliminating diseases such as lymphatic filariasis, onchocerciasis, and schistosomiasis. These efforts, along with commitments from organizations like the Global Fund to Fight AIDS, Tuberculosis, and Malaria, are essential in reducing the disease burden in resource-limited settings, especially in sub-Saharan Africa and Southeast Asia.

Another significant driver of the NTD treatment market is the focus on advancing drug formulations to address the unique challenges posed by neglected diseases. New treatments are being developed to improve efficacy, reduce treatment duration, and enhance patient compliance. According to Reuters, in May 2025, Novartis committed to continuing the production of malaria and leprosy medicines despite potential funding cuts. The company produces 28 million malaria treatment courses annually, mostly sold at not-for-profit prices. Despite challenges from reduced international aid, Novartis remains dedicated to supplying essential medicines, investing nearly USD 490 million in research for malaria and neglected tropical diseases. Despite potential challenges in global health funding, such as cuts in official development assistance, these companies continue to play a vital role in ensuring that treatments remain available to those who need them the most.

In terms of technological advancements, the integration of novel drug delivery systems and digital health innovations is improving both the effectiveness and accessibility of treatments. Nanotechnology, for example, is being explored as a way to enhance the bioavailability of drugs, allowing for more effective treatments even in resource-constrained environments. In July 2025, Swiss medical authorities approved Coartem Baby (also known as Riamet Baby), the first malaria treatment specifically designed for newborns and infants weighing under 11 pounds. Developed by Medicines for Malaria Venture in collaboration with Novartis, the drug addresses a critical treatment gap. It is expected to be rolled out in several African nations, where malaria remains a leading cause of death among children under five. These innovations are not only improving therapeutic outcomes but also making treatments more accessible to populations that previously lacked reliable healthcare options. Additionally, mobile health technologies are helping to bridge the gap in healthcare access, enabling better disease monitoring and management in remote areas, further enhancing the market's potential.

These developments reflect a growing momentum in the NTD treatment space, driven by collaborative efforts between governments, pharmaceutical companies, and global health organizations. With new drug formulations, the commitment of major pharmaceutical players, and technological innovations, the market is poised to continue evolving in its mission to control and ultimately eradicate neglected tropical diseases.

Global Neglected Tropical Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neglected tropical disease treatment market report based on disease, product, and region:

  • Disease Outlook (Revenue, USD Million, 2021 - 2033)
  • Dengue
  • Rabies
  • Trachoma
  • Buruli Ulcer
  • Yaws
  • Leprosy
  • Chagas Disease
  • Human African Trypanosomiasis (Sleeping Sickness)
  • Leishmaniases
  • Soil-transmitted Helminthiases
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Drugs
    • Anti-Parasite
    • Antifungal
    • Antibiotics
    • Others
  • Vaccines
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-3-68038-787-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Neglected Tropical Disease Treatment Market: Disease Business Analysis

  • 4.1. Disease Market Share, 2024 & 2033
  • 4.2. Disease Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
  • 4.4. Dengue
    • 4.4.1. Dengue Market, 2021 - 2033 (USD Million)
  • 4.5. Rabies
    • 4.5.1. Rabies Market, 2021 - 2033 (USD Million)
  • 4.6. Trachoma
    • 4.6.1. Trachoma Market, 2021 - 2033 (USD Million)
  • 4.7. Buruli Ulcer
    • 4.7.1. Buruli Ulcer Market, 2021 - 2033 (USD Million)
  • 4.8. Yaws
    • 4.8.1. Yaws Market, 2021 - 2033 (USD Million)
  • 4.9. Leprosy
    • 4.9.1. Leprosy Market, 2021 - 2033 (USD Million)
  • 4.10. Chagas Disease
    • 4.10.1. Chagas Disease Market, 2021 - 2033 (USD Million)
  • 4.11. Human African Trypanosomiasis (Sleeping Sickness)
    • 4.11.1. Human African Trypanosomiasis (Sleeping Sickness) Market, 2021 - 2033 (USD Million)
  • 4.12. Leishmaniases
    • 4.12.1. Leishmaniases Market, 2021 - 2033 (USD Million)
  • 4.13. Soil-transmitted Helminthiases
    • 4.13.1. Soil-transmitted Helminthiases Market, 2021 - 2033 (USD Million)
  • 4.14. Others
    • 4.14.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Neglected Tropical Disease Treatment Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2033
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Drugs
    • 5.4.1. Drugs Market, 2021 - 2033 (USD Million)
    • 5.4.2. Anti-Parasite
      • 5.4.2.1. Anti-Parasite Market, 2021 - 2033 (USD Million)
    • 5.4.3. Antifungal
      • 5.4.3.1. Antifungal Market, 2021 - 2033 (USD Million)
    • 5.4.4. Antibiotics
      • 5.4.4.1. Antibiotics Market, 2021 - 2033 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Others Market, 2021 - 2033 (USD Million)
  • 5.5. Vaccines
    • 5.5.1. Vaccines Market, 2021 - 2033 (USD Million)

Chapter 6. Neglected Tropical Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Neglected Tropical Disease Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. F. Hoffmann-La Roche Ltd
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Disease Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Bayer AG
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Disease Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. GlaxoSmithKline plc
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Disease Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Novartis AG
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Disease Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Pfizer, Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Disease Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Eisai Co. Ltd.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Disease Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Sanofi
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Disease Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Astellas Pharma
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Disease Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Takeda Pharmaceutical Company Limited
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Disease Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Gilead Sciences.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Disease Benchmarking
      • 7.5.10.4. Strategic Initiatives
Show more
Product Code: GVR-3-68038-787-2

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global neglected tropical disease treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 5. Global neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 6. North America neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 7. North America neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 8. North America neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 9. U.S. neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 10. U.S. neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 11. Canada neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 12. Canada neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 13. Mexico neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 14. Mexico neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 15. Europe neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 16. Europe neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 17. Europe neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 18. UK neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 19. UK neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 20. Germany neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 21. Germany neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 22. France neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 23. France neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 24. Italy neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 25. Italy neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 26. Spain neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 27. Spain neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 28. Norway neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 29. Norway neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 30. Denmark neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 31. Denmark neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 32. Sweden neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 33. Sweden neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 34. Asia Pacific neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 35. Asia Pacific neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 36. Asia Pacific neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 37. Japan neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 38. Japan neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 39. China neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 40. China neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 41. India neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 42. India neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 43. Australia neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 44. Australia neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 45. South Korea neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 46. South Korea neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 47. Thailand neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 48. Thailand neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 49. Latin America neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 50. Latin America neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 51. Latin America neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 52. Brazil neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 53. Brazil neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 54. Argentina neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 55. Argentina neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 56. Middle East & Africa Neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 57. Middle East & Africa neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 58. Middle East & Africa neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 59. South Africa neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 60. South Africa neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 61. Saudi Arabia neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 62. Saudi Arabia neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 63. UAE neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 64. UAE neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 65. Kuwait neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 66. Kuwait neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Neglected tropical disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Neglected tropical disease treatment market dynamics
  • Fig. 12 Neglected tropical disease treatment market: Porter's five forces analysis
  • Fig. 13 Neglected tropical disease treatment market: PESTLE analysis
  • Fig. 14 Dengue market, 2021 - 2033 (USD Million)
  • Fig. 15 Rabies market, 2021 - 2033 (USD Million)
  • Fig. 16 Trachoma market, 2021 - 2033 (USD Million)
  • Fig. 17 Buruli ulcer market, 2021 - 2033 (USD Million)
  • Fig. 18 Yaws market, 2021 - 2033 (USD Million)
  • Fig. 19 Leprosy market, 2021 - 2033 (USD Million)
  • Fig. 20 Human african trypanosomiasis (sleeping sickness) market, 2021 - 2033 (USD Million)
  • Fig. 21 Leishmaniases market, 2021 - 2033 (USD Million)
  • Fig. 22 Soil-transmitted helminthiases market, 2021 - 2033 (USD Million)
  • Fig. 23 Others market, 2021 - 2033 (USD Million)
  • Fig. 24 Product market, 2021 - 2033 (USD Million)
  • Fig. 25 Drugs market, 2021 - 2033 (USD Million)
  • Fig. 26 Anti-Parasite market, 2021 - 2033 (USD Million)
  • Fig. 27 Antifungal market, 2021 - 2033 (USD Million)
  • Fig. 28 Antibiotics market, 2021 - 2033 (USD Million)
  • Fig. 29 Others market, 2021 - 2033 (USD Million)
  • Fig. 30 Vaccines market, 2021 - 2033 (USD Million)
  • Fig. 31 Neglected tropical disease treatment market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 France country dynamics
  • Fig. 46 France neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark country dynamics
  • Fig. 56 Denmark neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 China country dynamics
  • Fig. 61 China neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 India country dynamics
  • Fig. 63 India neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Australia country dynamics
  • Fig. 65 Australia neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea country dynamics
  • Fig. 67 South Korea neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 75 MEA neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!